Benzinga's Top Downgrades

Analysts at Mizuho downgraded Boston Scientific Corporation BSX from “buy” to “neutral.” BSX's shares closed at $5.21 yesterday. Boston Scientific's trailing-twelve-month ROA is 3.10%. The Benchmark Company downgraded Manhattan Associates Inc MANH from “buy” to “hold.” MANH's shares closed at $42.59 yesterday. Manhattan Associates' trailing-twelve-month profit margin is 12.87%. RBC Capital Markets downgraded Agrium Inc AGU to “sector perform.” AGU's shares closed at $67.88 yesterday. Agrium's trailing-twelve-month operating margin is 12.86%. Analysts at Roth Capital downgraded VIVUS Inc VVUS to “neutral.” VIVUS' shares closed at $10.40 yesterday. VIVUS' trailing-twelve-month ROE is -37.88%. To get these ratings delivered in real-time, sign up for a free trial of Benzinga Pro
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: DowngradesAnalyst RatingsApplication SoftwareInformation TechnologyTop Downgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!